Zhejiang Hisun Pharmaceutical Co Ltd

600267

Company Profile

  • Business description

    Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.

  • Contact

    No. 46 Waisha Road
    Jiaojiang District
    Zhejiang Province
    Taizhou318000
    CHN

    T: +86 4001180618

    http://www.hisunpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    8,751

Stocks News & Analysis

stocks

Meta earnings: AI-driven improvements in top line fail to impress investors

We reiterate our fair value estimate for wide-moat Meta and view the after-market selloff as an overreaction
stocks

Chart of the Week: CGT reform strengthens the case for dividend investing

Why dividend stocks are gaining an edge after tax reform.
stocks

Big dividend raise from ASX mainstay

Strong commodity pricing helps mining giant.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,122.7062.80-0.68%
CAC 408,485.6477.370.92%
DAX 4025,612.03151.550.60%
Dow JONES (US)52,208.06613.921.19%
FTSE 10010,897.2711.14-0.10%
HKSE25,858.8850.960.20%
NASDAQ25,122.18679.242.78%
Nikkei 22561,867.43433.240.71%
NZX 50 Index13,762.78213.89-1.53%
S&P 5007,437.63121.481.66%
S&P/ASX 2008,967.7057.10-0.63%
SSE Composite Index3,804.6923.78-0.62%

Market Movers